Grants and Contributions:
Title:
Development of fecal incontinence barrier cream
Agreement Number:
998833
Agreement Value:
$43,840.00
Agreement Date:
Dec 3, 2022 - Jul 28, 2023
Description:
Scotiaderm Inc. will develop an advanced fecal incontinence prevention and possibly treatment system. It includes a proprietary OTC topical formulation protected by a non-medicated skin barrier film.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Port Williams, Nova Scotia, CA B3J 0J2
Reference Number:
172-2022-2023-Q3-998833
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
739815330
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 3,000 dollars.
Amendment Date
May 16, 2023
Recipient's Legal Name:
Scotiaderm Inc.
Federal Riding Name:
Halifax
Federal Riding Number:
12005
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: